Rakuten TV Launches its AVOD Service in Europe
15.10.2019 11:30:00 EEST | Business Wire | Press release
Rakuten TV, one of the leading video-on-demand platforms in Europe, today announced the launch of its first AVOD - ad-supported video-on-demand - channels within the platform. This new business model will allow viewers to watch a wide range of content for free.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191015005048/en/
Rakuten TV's new UI 4.0 including "Free" section (Photo: Rakuten TV)
The free section of Rakuten TV will launch with an initial offer including Hollywood and local content to be expanded to additionally include exclusive Rakuten content, TV series, documentary series, news and sport channels in the coming months - with a combined linear and on-demand offer.
Among the exclusive content, Rakuten TV will present on its AVOD channel Matchday - Inside FC Barcelona, the new documentary series about FC Barcelona from the inside, offering previously unseen and exclusive scenes from the players’ private lives. Narrated by John Malkovich, Matchday – Inside FC Barcelona is a creation of Barça Studios, FC Barcelona’s own production house, in collaboration with Kosmos Studios, Rakuten, Inc. in association with Rakuten H Collective Studio and Producciones del Barrio.
Expanding its business model proposition, Rakuten TV will be the first to combine TVOD and AVOD products across Europe, meeting the changing needs of viewers. The free ad-supported channels will enrich the original proposition of Rakuten TV - Your Cinema at Home - offering Smart TV viewers the best cinematic experience with the latest new releases in the best audiovisual quality. Thanks to the presence of a remote control button providing direct access to the app on major Smart TVs, Rakuten TV content will be just a click away for over 30 million households across Europe.
In a time when the streaming industry is increasingly changing and exploring avenues such as AVOD, Rakuten TV is proud to pioneer this trend in Europe as the main VOD platform combining different business models - TVOD, AVOD and SVOD - which are oriented around meeting all audience needs.
Jacinto Roca, Rakuten TV Founder and CEO, stated: “We are incredibly proud to take this step after having tripled our presence in Europe just a few months ago. Rakuten TV continues to evolve rapidly alongside consumer trends within the industry, where there is a clear trend of advertisers moving away from linear TV and towards VOD. This is a unique opportunity for Rakuten TV which has already direct access to millions of European households through its branded remote control button of the main Smart TV brands. This is the mere beginning of a huge project which will see the launch of additional channels and exclusive content in the coming months”.
The service will be available in beta version, across the complete 2019 SMART TV line up, and will be progressively rolled out in other platforms including mobile and desktop.
Advertising sales will be managed by Rakuten Marketing, a subsidiary of Rakuten Inc. Nick Stamos, Rakuten Marketing CEO, stated: “Advertisers and agencies are eager to be among the first to showcase their brands in this exclusive and groundbreaking advertising platform. As VOD is emerging as a powerful media channel, our clients have been anticipating this launch from RakutenTV, so we are very excited to bring this new proposition to market across Europe.”
Rakuten Viber, Rakuten’s instant messaging service, will also be involved in the project, leveraging its community of 2 million Barça fans to promote Matchday.
Nielsen will be the data partner (DMP-data management platform) used to target advertisements at a digital level
This news comes alongside a renewed platform design for Rakuten TV, with a more attractive look & feel, a more intuitive user interface and a simpler user journey. Within the new interface, viewers will discover the new channel offering featuring ad-supported content inside the ‘free’ section implemented within the header menu.
The announcement took place during the conference “AVOD on the Rise” at MIPCOM 2019, where Founder and CEO of Rakuten TV, Jacinto Roca, spoke about the AVOD industry and its evolution with other top players in the entertainment field.
Rakuten TV
Rakuten TV is one of the leading Video On-Demand platforms in Europe. It offers a TVOD service (Transactional VOD) providing viewers a true cinematic experience with the latest new releases in the best audiovisual quality. It also includes an AVOD (Advertising VOD) section, Rakuten TV Free, in a blend of thematic channels embracing Hollywood classics, local, exclusive and themed content, all for free.
Rakuten TV is available in 42 countries and forms part of Rakuten, Inc., one of the world’s leading internet services companies, offering a wide variety of services for consumers and businesses, with a focus on e-commerce, fintech and digital content. Rakuten, headquartered in Japan, is also known for its partnerships with FC Barcelona, the NBA, the Golden State Warriors, Davis Cup and Spartan Race.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191015005048/en/
Contact information
Media Contacts:
For further information please contact:
Premier PR – Rakuten TV
Charlie Wainwright - Premier PR on behalf of Rakuten TV
charlie.wainwright@premiercomms.com
0207 292 7372
Rakuten TV
Fabiana Cumia – Communication Director – fabiana.cumia@rakuten.com
Iraia Arza – PR & Communication Specialist – iraia.arza@rakuten.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom